(Reuters) -The U.S. Food and Drug Administration is probing the death of a patient who developed harmful antibodies after taking Takeda Pharmaceuticals' blood disorder therapy, the health regulator said on Friday.
The pediatric patient died about 10 months after starting Takeda's drug Adzynma as a preventive therapy, the agency said.
The child had congenital thrombotic thrombocytopenic purpura (cTTP), an inherited condition that causes blood clots in small vessels and can lead to organ damage.
The FDA said the child developed antibodies that blocked the activity of ADAMTS13, an enzyme critical for blood clotting.
Takeda did not immediately respond to Reuters request for comment.
Adzynma, approved in 2023 as the first therapy for cTTP, replaces the ADAMTS13 protein to help prevent dangerous blood clots.
The agency added it has received multiple postmarketing reports of patients developing neutralizing antibodies to ADAMTS13 after treatment with Adzynma.
(Reporting by Kamal Choudhury in Bengaluru; Editing by Vijay Kishore)
LATEST POSTS
- 1
The pace of hiring just fell to the lowest since 2011, outside of the pandemic - 2Don't miss Jupiter shining close to the waning gibbous moon on Dec. 7
- 3Opening Achievement: 8 Methodologies for Compelling Using time productively
- 4Pedal Power: Divulging Well known Bike Brands for Each Cyclist
- 5Glamour Shots once ruled the mall. I went to one of the last ones standing.
- Charli xcx recorded original songs for 'Wuthering Heights' — what to know about the new album for Margot Robbie's film
- Popular Home Rug Series For You
- Did Japan’s PM Actually Back the Memecoin Bearing Her Name?
- Danish warship sunk by famed British admiral discovered after 225 years
- Most loved Seared Chicken: Which Chain Rules?
- Is 'Stranger Things' releasing one last episode? The 'Conformity Gate' fan theory explained as speculation mounts.
- Judge approves Purdue Pharma’s new $7B opioid settlement with the Sacklers
- Help Your Efficiency with These Work area Updates
- Islamic State group militants claim capture and execution of a Nigerian brigadier general
